Shuko Takeda

5.3k total citations
58 papers, 3.4k citations indexed

About

Shuko Takeda is a scholar working on Physiology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Shuko Takeda has authored 58 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Physiology, 17 papers in Cellular and Molecular Neuroscience and 15 papers in Molecular Biology. Recurrent topics in Shuko Takeda's work include Alzheimer's disease research and treatments (38 papers), Neuroscience and Neuropharmacology Research (11 papers) and Dementia and Cognitive Impairment Research (10 papers). Shuko Takeda is often cited by papers focused on Alzheimer's disease research and treatments (38 papers), Neuroscience and Neuropharmacology Research (11 papers) and Dementia and Cognitive Impairment Research (10 papers). Shuko Takeda collaborates with scholars based in Japan, United States and Armenia. Shuko Takeda's co-authors include Ryuichi Morishita, Naoyuki Sato, Hiromi Rakugi, Bradley T. Hyman, Daisuke Takeuchi, Hitomi Kurinami, Mitsuru Shinohara, Kozue Uchio‐Yamada, Susanne Wegmann and Tadafumi Hashimoto and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Shuko Takeda

58 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shuko Takeda Japan	31	2.0k	1.0k	901	676	403	58	3.4k
Mitsuru Shinohara Japan	29	2.0k 1.0×	1.0k 1.0×	899 1.0×	515 0.8×	306 0.8×	59	3.3k
Philip B. Verghese United States	22	2.0k 1.0×	1000 1.0×	806 0.9×	631 0.9×	336 0.8×	41	3.2k
J. Scott Miners United Kingdom	36	2.0k 1.0×	937 0.9×	1.2k 1.3×	497 0.7×	375 0.9×	68	3.8k
Tom Kasten United States	15	2.2k 1.1×	846 0.8×	765 0.8×	617 0.9×	348 0.9×	19	3.3k
Leon M. Tai United States	30	1.6k 0.8×	908 0.9×	818 0.9×	457 0.7×	260 0.6×	63	2.9k
Inés Moreno‐González United States	30	1.7k 0.8×	1.2k 1.1×	944 1.0×	607 0.9×	244 0.6×	57	3.2k
Lynn M. Bekris United States	26	1.3k 0.7×	1.0k 1.0×	910 1.0×	358 0.5×	237 0.6×	52	3.0k
Rena Li United States	23	1.5k 0.7×	744 0.7×	809 0.9×	513 0.8×	257 0.6×	60	2.8k
Laura Gasparini Italy	32	2.1k 1.1×	1.7k 1.7×	597 0.7×	720 1.1×	551 1.4×	66	3.9k

Countries citing papers authored by Shuko Takeda

Since Specialization

Citations

This map shows the geographic impact of Shuko Takeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shuko Takeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shuko Takeda more than expected).

Fields of papers citing papers by Shuko Takeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shuko Takeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shuko Takeda. The network helps show where Shuko Takeda may publish in the future.

Co-authorship network of co-authors of Shuko Takeda

This figure shows the co-authorship network connecting the top 25 collaborators of Shuko Takeda. A scholar is included among the top collaborators of Shuko Takeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shuko Takeda. Shuko Takeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Takahashi, Hiroto, Yoichi Takami, Shuko Takeda, et al.. (2024). Imaging Biomarker for Early-Stage Alzheimer Disease: Utility of Hippocampal Histogram Analysis of Diffusion Metrics. American Journal of Neuroradiology. 45(3). 320–327. 1 indexed citations

Takeda, Shuko, T. Nakajima, Yoichi Takami, et al.. (2023). Antiepileptic Drugs Modulate Alzheimer-Related Tau Aggregation in a Neuronal Activity-Independent Manner. Dementia and Geriatric Cognitive Disorders. 52(2). 108–116. 4 indexed citations

Takeda, Shuko, T. Nakajima, Haruo Takeshita, et al.. (2023). High-Fat Diet-Induced Diabetic Conditions Exacerbate Cognitive Impairment in a Mouse Model of Alzheimer's Disease Via a Specific Tau Phosphorylation Pattern. The Journal of Prevention of Alzheimer s Disease. 11(1). 138–148. 1 indexed citations

Nomura, Sachiko, et al.. (2022). Peripheral Aβ acts as a negative modulator of insulin secretion. Proceedings of the National Academy of Sciences. 119(12). e2117723119–e2117723119. 9 indexed citations

Nakajima, T., Shuko Takeda, Yoichi Takami, et al.. (2022). A novel chronic dural port platform for continuous collection of cerebrospinal fluid and intrathecal drug delivery in free-moving mice. Fluids and Barriers of the CNS. 19(1). 31–31. 2 indexed citations

Amaral, Ana C., Beatriz Gomez Perez‐Nievas, Alicia González‐Martínez, et al.. (2021). Isoform-selective decrease of glycogen synthase kinase-3-beta (GSK-3β) reduces synaptic tau phosphorylation, transcellular spreading, and aggregation. iScience. 24(2). 102058–102058. 24 indexed citations

Yamaguchi, Tomoko, et al.. (2019). Effect of heat stress on blood-brain barrier integrity in iPS cell-derived microvascular endothelial cell models. PLoS ONE. 14(9). e0222113–e0222113. 17 indexed citations

Takeda, Shuko, Hiromi Rakugi, & Ryuichi Morishita. (2019). Roles of vascular risk factors in the pathogenesis of dementia. Hypertension Research. 43(3). 162–167. 51 indexed citations

Takeda, Shuko. (2019). Tau Propagation as a Diagnostic and Therapeutic Target for Dementia: Potentials and Unanswered Questions. Frontiers in Neuroscience. 13. 1274–1274. 39 indexed citations

10.

Kastanenka, Ksenia V., María Calvo-Rodríguez, Steven S. Hou, et al.. (2019). Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology. Scientific Reports. 9(1). 8964–8964. 32 indexed citations

11.

György, Bence, Camilla Lööv, Mikołaj Piotr Zaborowski, et al.. (2018). CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease. Molecular Therapy — Nucleic Acids. 11. 429–440. 128 indexed citations

12.

Nicholls, Samantha B., Sarah L. DeVos, Caitlin Commins, et al.. (2017). Characterization of TauC3 antibody and demonstration of its potential to block tau propagation. PLoS ONE. 12(5). e0177914–e0177914. 31 indexed citations

13.

Wegmann, Susanne, Samantha B. Nicholls, Shuko Takeda, Zhanyun Fan, & Bradley T. Hyman. (2016). Formation, release, and internalization of stable tau oligomers in cells. Journal of Neurochemistry. 139(6). 1163–1174. 50 indexed citations

14.

Hori, Yukiko, Shuko Takeda, Hansang Cho, et al.. (2014). A Food and Drug Administration-approved Asthma Therapeutic Agent Impacts Amyloid β in the Brain in a Transgenic Model of Alzheimer Disease. Journal of Biological Chemistry. 290(4). 1966–1978. 61 indexed citations

15.

Takeda, Shuko, et al.. (2013). Increased blood–brain barrier vulnerability to systemic inflammation in an Alzheimer disease mouse model. Neurobiology of Aging. 34(8). 2064–2070. 105 indexed citations

16.

Takeda, Shuko, Naoyuki Sato, Hiromi Rakugi, & Ryuichi Morishita. (2011). Molecular mechanisms linking diabetes mellitus and Alzheimer disease: beta-amyloidpeptide, insulin signaling, and neuronal function. Molecular BioSystems. 7(6). 1822–1827. 120 indexed citations

17.

Takeda, Shuko, Naoyuki Sato, Kozue Uchio‐Yamada, et al.. (2010). Diabetes-accelerated memory dysfunction via cerebrovascular inflammation and Aβ deposition in an Alzheimer mouse model with diabetes. Proceedings of the National Academy of Sciences. 107(15). 7036–7041. 407 indexed citations

18.

Takeda, Shuko, Naoyuki Sato, Hiromi Rakugi, & Ryuichi Morishita. (2010). Plasma β-amyloid as potential biomarker of Alzheimer disease: possibility of diagnostic tool for Alzheimer disease. Molecular BioSystems. 6(10). 1760–1766. 28 indexed citations

19.

Sato, Naoyuki, Hitomi Kurinami, Daisuke Takeuchi, et al.. (2010). Reduction of Brain β-Amyloid (Aβ) by Fluvastatin, a Hydroxymethylglutaryl-CoA Reductase Inhibitor, through Increase in Degradation of Amyloid Precursor Protein C-terminal Fragments (APP-CTFs) and Aβ Clearance. Journal of Biological Chemistry. 285(29). 22091–22102. 99 indexed citations

20.

Takeda, Shuko, Naoyuki Sato, Kazue Niisato, et al.. (2009). Validation of Aβ1–40 administration into mouse cerebroventricles as an animal model for Alzheimer disease. Brain Research. 1280. 137–147. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact